(19)
(11) EP 4 562 427 A2

(12)

(88) Date of publication A3:
11.04.2024

(43) Date of publication:
04.06.2025 Bulletin 2025/23

(21) Application number: 23847568.5

(22) Date of filing: 27.07.2023
(51) International Patent Classification (IPC): 
G01N 33/543(2006.01)
G16B 25/10(2019.01)
G16H 50/20(2018.01)
G01N 33/68(2006.01)
G16B 40/30(2019.01)
(52) Cooperative Patent Classification (CPC):
G16H 50/20; G01N 2800/2821; G01N 33/6896; G01N 33/564; G01N 2800/2835; G16H 10/40; G16H 50/30; G16H 50/70
(86) International application number:
PCT/US2023/071129
(87) International publication number:
WO 2024/026413 (01.02.2024 Gazette 2024/05)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 27.07.2022 US 202263369561 P

(71) Applicant: Durin Life Sciences, Inc.
Stratford, New Jersey 08084 (US)

(72) Inventors:
  • DEMARSHALL, Cassandra
    Voorhees, NJ 08043 (US)
  • VIVIANO, Jeffrey
    Voorhees, NJ 08043 (US)

(74) Representative: Grünecker Patent- und Rechtsanwälte PartG mbB 
Leopoldstraße 4
80802 München
80802 München (DE)

   


(54) EARLY DETECTION AND MONITORING OF NEURODEGENERATIVE DISEASES USING A MULTI-DISEASE DIAGNOSTIC PLATFORM